Today: 7 February 2026
Subscribe
Browse Category

Health News News 23 August 2025 - 16 December 2025

California Vega Farms Egg Recall: 63 Sick, 13 Hospitalized in Salmonella Outbreak—How to Identify Affected Eggs

California Vega Farms Egg Recall: 63 Sick, 13 Hospitalized in Salmonella Outbreak—How to Identify Affected Eggs

SACRAMENTO, Calif. (Dec. 15, 2025) — A Salmonella Enteritidis outbreak in California has been linked to recalled Vega Farms in-shell brown eggs, with state health officials reporting 63 illnesses and 13 hospitalizations (and no deaths) tied to the outbreak strain as of Dec. 5, according to the California Department of Public Health (CDPH). California Department of Public Health The recall centers on eggs distributed in Northern California—primarily the Sacramento and Davis areas—and sold not only through retail outlets but also supplied to restaurants and farmers markets, officials said. California Department of Public Health+1 What’s driving the warning: testing, inspection, and
16 December 2025
Vega Farms Egg Recall Update: California Links Salmonella Outbreak to Dixon Farm Eggs; 63 Sick, 13 Hospitalized

Vega Farms Egg Recall Update: California Links Salmonella Outbreak to Dixon Farm Eggs; 63 Sick, 13 Hospitalized

SACRAMENTO, Calif. (Dec. 13, 2025) — California health officials are urging residents and businesses across parts of Northern California to stop eating, selling, or serving certain Vega Farms in-shell eggs after the products were linked to a Salmonella Enteritidis outbreak that has already sickened dozens of people. California Department of Public Health+1 The California Department of Public Health (CDPH) says that 63 California residents were reported ill as of Dec. 5, 2025, including 13 hospitalizations, with no deaths reported. The eggs were voluntarily recalled by Vega Farms, Inc. on Dec. 5, 2025, and the state has since released details to
13 December 2025
McCain Pizza Pockets Recall Australia 2025: Cheese & Bacon 400g Pulled from Woolworths, Coles and IGA After Plastic and Metal Contamination Warning

McCain Pizza Pockets Recall Australia 2025: Cheese & Bacon 400g Pulled from Woolworths, Coles and IGA After Plastic and Metal Contamination Warning

Australians are being urged to check their freezers after McCain Foods (Aust) Pty Ltd issued a nationwide recall for McCain Cheese & Bacon Pizza Pockets (400g) following reports of foreign material in the product. The recall, published on Friday, 12 December 2025, covers items sold through major supermarkets and online deliveries across the country. Food Standards Australia New Zealand+1 The warning is straightforward: do not eat the affected pizza pockets. Food safety authorities say food products containing plastic and/or metal can cause illness or injury if consumed, and the product should be returned to the place of purchase for a
12 December 2025
Johnson & Johnson (JNJ) Stock After Hours on December 9, 2025: New Cancer Breakthrough, Dividend Payout and What to Watch Before the December 10 Open

Johnson & Johnson (JNJ) Stock After Hours on December 9, 2025: New Cancer Breakthrough, Dividend Payout and What to Watch Before the December 10 Open

Key Takeaways Below, we’ll walk through what happened to Johnson & Johnson stock after the bell on December 9 and what investors should watch before the U.S. market opens on Wednesday, December 10, 2025. 1. How Johnson & Johnson Stock Traded on December 9, 2025 Regular session: hot open, cold close On Tuesday, December 9, 2025, Johnson & Johnson shares: Volume came in at roughly 5–7 million shares, around or slightly below JNJ’s recent average daily volume of ~6.8 million shares, suggesting a normal‑liquidity, mild risk‑off session rather than a panic move. StockInvest+1 Early in the day, JNJ actually helped
10 December 2025
···
Moderna (MRNA) Stock Jumps on New Vaccine Safety Data – Latest News, Forecast & Analysis for December 5, 2025

Moderna (MRNA) Stock Jumps on New Vaccine Safety Data – Latest News, Forecast & Analysis for December 5, 2025

Moderna, Inc. (NASDAQ: MRNA) closed today as one of the more talked‑about healthcare names on Wall Street, with the stock rebounding sharply after a bruising year of falling COVID-19 vaccine sales, pipeline setbacks, and rising regulatory risk. Today’s move comes as investors digest a huge, real‑world French study supporting the long‑term safety and effectiveness of mRNA COVID vaccines, fresh details of a $1.5 billion loan deal, and updated guidance pointing to a slow path back toward growth and eventual profitability. The Chronicle-Journal+1 Below is a deep dive into where Moderna stock stands right now, what’s driving today’s rally, and how
5 December 2025
·
Costco Issues Urgent Recall of Caesar Salad and Chicken Sandwich Over Plastic Contamination Risk (November 25, 2025)

Costco Issues Urgent Recall of Caesar Salad and Chicken Sandwich Over Plastic Contamination Risk (November 25, 2025)

As of Tuesday, November 25, 2025, Costco is still urging members to stop eating certain ready‑to‑eat Caesar salad products after plastic fragments were found in the dressing packets used in those meals. The nationwide warehouse chain has recalled two popular deli items — its prepared Caesar Salad and Chicken Sandwich with Caesar Salad — in cooperation with dressing supplier Ventura Foods, following a member letter first posted on November 7. cdn.bfldr.com+2EatingWell+2 Today, fresh coverage from outlets in the U.S. and abroad is amplifying the warning, underscoring that some shoppers may still have these products or dressing packets in their refrigerators.
25 November 2025
Yoplait YOP Drinkable Yogurt Recall in Canada: Full List of Affected Products, Best-Before Dates and What Shoppers Should Do – November 24, 2025

Yoplait YOP Drinkable Yogurt Recall in Canada: Full List of Affected Products, Best-Before Dates and What Shoppers Should Do – November 24, 2025

Montreal / Ottawa – November 24, 2025 — Canadian parents and yogurt lovers are being urged to check their fridges after a nationwide recall of Yoplait brand YOP drinkable yogurt over fears that some bottles may contain small pieces of plastic. The recall, led by the Canadian Food Inspection Agency (CFIA), covers all flavours of 200 mL YOP drinkable yogurt, including several multi-pack formats, sold in grocery stores across the country. The recall has been classified as Class 1, CFIA’s most serious category, indicating a high risk that consuming the product could lead to serious health problems if the contamination
24 November 2025
Intellia Therapeutics (NTLA) plunges after patient death in pivotal CRISPR trial; Q3 update, analyst downgrades and what to watch next [Nov. 7, 2025]

Intellia Therapeutics (NTLA) plunges after patient death in pivotal CRISPR trial; Q3 update, analyst downgrades and what to watch next [Nov. 7, 2025]

What happened today Intellia Therapeutics (NASDAQ: NTLA) is under intense pressure after the company said the patient who experienced Grade 4 liver enzyme and bilirubin elevations in its Phase 3 MAGNITUDE study later died. In a Nov. 6 business update, CEO John Leonard said the treating physician cited “complicating comorbidities,” and Intellia is working with investigators and outside experts on a risk‑mitigation plan for nexiguran ziclumeran (nex‑z; NTLA‑2001), its in vivo CRISPR therapy for transthyretin amyloidosis (ATTR). The FDA’s clinical holds on MAGNITUDE (ATTR‑CM) and MAGNITUDE‑2 (ATTR‑PN) are still in effect pending a formal hold letter. GlobeNewswire+1 Sell‑side reaction was
7 November 2025
··
Salmonella Scare: FDA Upgrades Egg Recall to ‘Highest Risk’ — Are Your Eggs Affected?

Salmonella Scare: FDA Upgrades Egg Recall to ‘Highest Risk’ — Are Your Eggs Affected?

Egg supplies and prices remain the backdrop to this story. 163 million U.S. poultry have died from avian flu since 2022, cutting the egg-laying flock by ~11% vs. 2019 reuters.com. Consumers have seen sticker shock – in some cities eggs cost $8–$10 per dozen reuters.com. This summer’s massive recall (over 6 million eggs from one farm) is partly why the FDA reclassified it at the top risk level newsweek.com foodnetwork.com. How to stay safe: Food-safety experts stress vigilance with eggs. Salmonella is “a leading cause of foodborne illness” in the U.S. foodpoisoningnews.com. The FDA and CDC advise thoroughly cooking eggs
22 October 2025
GRAIL Inc. Stock Rises on Samsung Partnership and Cancer-Test News

GRAIL Stock Rockets on Samsung Mega-Deal and Cancer Test Breakthrough

Samsung Alliance Triggers Record Rally GRAIL’s stock price exploded after the company announced a strategic alliance with Samsung on October 16. Under the deal, Samsung C&T will invest $110 million in GRAIL and become the exclusive distributor of the Galleri multi-cancer blood test in South Korea, with rights to expand into Japan and Singaporets2.tech. Samsung Electronics is also participating and plans to explore AI and health-data collaborations with GRAILts2.tech. This marks a major vote of confidence from one of Asia’s largest conglomerates. The partnership is expected to close by early 2026 (pending conditions) and gives GRAIL a powerful commercialization partner in
20 October 2025
··
Achieve Life Sciences Skyrockets on FDA Boost – Is This Nicotine Addiction Breakthrough a Game Changer?

Achieve Life Sciences Skyrockets on FDA Boost – Is This Nicotine Addiction Breakthrough a Game Changer?

Stock Price Surge & Recent Performance Achieve Life Sciences stock exploded higher on the FDA news, reflecting growing optimism around cytisinicline’s prospects. In pre-market trading on Oct. 17, ACHV jumped about 22.7% after the company revealed it received a rare FDA Commissioner’s National Priority Voucher (CNPV) for cytisinicline’s vaping cessation indication investing.com. This rally propelled the shares to multi-month highs in the mid-$3 range. Earlier in the week, ACHV had already begun gaining momentum – on Oct. 15 the stock broke above its 200-day moving average (~$2.81) and hit $3.19 marketbeat.com, a bullish technical signal. As of Thursday’s close (Oct.
17 October 2025
··
Kenvue (KVUE) Stock Plummets to Record Low Amid Talc Lawsuit and Tylenol Scare

Kenvue (KVUE) Stock Plummets to Record Low Amid Talc Lawsuit and Tylenol Scare

Stock Hits a 52-Week Low on Legal Woes Kenvue’s shares collapsed to an all-time low since their mid-2023 IPO, closing around $14 after Thursday’s 13.2% plunge stocktwits.com. The one-day drop – Kenvue’s worst on record – was triggered by headline risks that blindsided investors. By early Friday, October 17, the stock stabilized slightly (up about 0.6% in pre-market trading) after the rout stocktwits.com. Still, at roughly 40% below its IPO price, the Johnson & Johnson spinoff has seen its market capitalization shrink to about $30–31 billion reuters.com. This dramatic sell-off came despite broader markets being relatively calm – the S&P
17 October 2025
··
INVO Fertility (NASDAQ: IVF) Stock Skyrockets 90% as Fertility Boom Fuels Frenzy

INVO Fertility (NASDAQ: IVF) Stock Skyrockets 90% as Fertility Boom Fuels Frenzy

Stock Price Soars Nearly 90% in One Day INVO Fertility’s stock took investors on a wild ride on Oct. 16, skyrocketing almost 90% by the closing bellreuters.com. Shares opened at just $0.75 and, in an astonishing surge, hit $1.43 by day’s end (after touching $2+ at the peak)reuters.com. To put the move in perspective, INVO’s daily gain far outpaced the broader market, and such a jump is highly unusual – even in the volatile biotech sector. Trading volume exploded to over 108 million sharesreuters.com, dwarfing the typical daily volume (around ~33,000 shares) and exceeding the company’s entire share float many
16 October 2025
·
GRAIL Inc. Stock Rises on Samsung Partnership and Cancer-Test News

GRAIL Inc. Stock Rises on Samsung Partnership and Cancer-Test News

Strategic Samsung Partnership GRAIL’s shares surged after it announced a deal on Oct. 16 to partner with Samsung in Asia. The binding Letter of Intent involves Samsung C&T and Samsung Electronics investing $110 million in GRAIL at $70.05 per share, with Samsung C&T to distribute the Galleri multi-cancer screening test in South Koreainvesting.comprnewswire.com. This collaboration gives Samsung “a strong foothold for expanding into the cancer screening field”, according to Jaywoo Kim, EVP of Samsung C&Tprnewswire.com. GRAIL’s President of International Business, Sir Harpal Kumar, said the deal “strengthens our balance sheet and provides further cash runway” as the company advances toward test
16 October 2025
··
Genprex (NASDAQ:GNPX) Stock Skyrockets 40% on Lung Cancer Gene Therapy Breakthrough

Genprex (NASDAQ:GNPX) Stock Skyrockets 40% on Lung Cancer Gene Therapy Breakthrough

Stock Price & Recent Performance Genprex shares have been extremely volatile. After surging over 30% during regular hours on Oct 14, 2025, to about $0.25, the stock jumped another 41% in after-hours trading (October 14) to roughly $0.36 on the cancer data announcement benzinga.com benzinga.com. That rally brought the stock briefly near its 30-day resistance around $0.26 ainvest.com. Before this spike, GNPX had been trading around $0.20. Over the last five trading days the stock was up about 25.6%, although year‐to‐date it was still down roughly 70% benzinga.com. For context, GNPX’s 52-week high is ~$4.09 (achieved in 2024) and its
15 October 2025
···
Spruce Biosciences Skyrockets on FDA Breakthrough – Will SPRB’s Rally Last or Fade?

Spruce Biosciences Skyrockets on FDA Breakthrough – Will SPRB’s Rally Last or Fade?

Stock Performance & Recent Price Action Spruce Biosciences’ stock has been on a wild ride in early October 2025. Heading into this period, SPRB was a little-known micro-cap biotech trading in the high single digits (post-reverse-split). At the close on Oct 3, 2025, shares stood at $8.82 (market cap ~$4.8M)stocktitan.net after a period of relatively low activity. That calm shattered on Oct 6, when news of an FDA breakthrough designation sent the stock skyrocketing. SPRB opened the day with a huge gap up and at one point surged by 250–300% intraday, hitting roughly $31–$32 per sharebenzinga.comstocktwits.com. Benzinga reported Spruce trading
6 October 2025
·
‘Hoarse Voice’ Could Be COVID: “Stratus” Variant Surges—Symptoms Doctors Flag, Where It’s Rising, and What Still Works

‘Hoarse Voice’ Could Be COVID: “Stratus” Variant Surges—Symptoms Doctors Flag, Where It’s Rising, and What Still Works

What is the “Stratus” COVID variant? “Stratus” is the colloquial name for XFG, a recombinant Omicron descendant (from LF.7 and LP.8.1.2). WHO added XFG to its monitoring list in late June and, based on available evidence, concluded the “additional public‑health risk … is low.” WHO’s lab summary notes spike‑protein changes (e.g., at positions 478 and 487) that can modestly increase immune escape compared with earlier JN.1‑family strains. World Health Organization Globally, XFG gained speed over the summer. WHO’s dashboard reports XFG was ~67% of submitted sequences in the week ending 31 Aug 2025; the runner‑up, NB.1.8.1 (“Nimbus”), accounted for ~21%.
28 September 2025
Possible Life on Mars, ‘Black Hole Stars’ and a Global Diabetes Bombshell – Science News Roundup (Sept 15–16, 2025)

Possible Life on Mars, ‘Black Hole Stars’ and a Global Diabetes Bombshell – Science News Roundup (Sept 15–16, 2025)

NASA Rover Finds Possible Biosignature – Closest Hint Yet of Life on Mars In a sensational development for astrobiology, NASA announced that Perseverance has collected a Mars rock sample that “could preserve evidence of ancient microbial life” nasa.gov. The rover drilled the sample, nicknamed “Sapphire Canyon,” from an ancient riverbed formation rich in clay – exactly the kind of environment that on Earth traps and preserves organic remains nasa.gov nasa.gov. Inside the rock, scientists detected certain organic molecules and chemical patterns that are considered potential biosignatures, meaning they might be remnants of past life (though not yet proof of it)
16 September 2025
COVID Booster Shocker, Pharma Mega-Deals & Alzheimer’s Breakthroughs – Global Health Roundup (Aug 28–29, 2025)

COVID Booster Shocker, Pharma Mega-Deals & Alzheimer’s Breakthroughs – Global Health Roundup (Aug 28–29, 2025)

Drug Approvals & Clinical Trial Results Updated COVID Boosters Get Narrow Nod: The U.S. FDA approved new fall COVID-19 booster shots from Pfizer/BioNTech and Moderna on August 27 – but with strict eligibility limits. Only adults 65+ and younger people with certain medical conditions are cleared for the updated vaccines, and emergency use authorizations for routine use in healthy children were removed realeconomy.rsmus.com. Health experts immediately sounded alarms: the Infectious Diseases Society of America blasted the “narrowed” booster rollout as contrary to scientific guidance and a risk to lives cidrap.umn.edu. They warn these restrictions could hinder access, especially for children,
29 August 2025
·
Breakthrough Drugs, Big Deals & Public Health Alerts – Biotech and Health News Roundup (Aug 22–23, 2025)

Breakthrough Drugs, Big Deals & Public Health Alerts – Biotech and Health News Roundup (Aug 22–23, 2025)

Regulatory Approvals & Clinical Milestones Pharma & Biotech Industry Moves Startups & Innovation Highlights Medical Research & Innovation Public Health & Policy Developments Sources: Ionis HAE drug approval pharmexec.com biopharmadive.com; BioPharmaDive on Dawnzera pricing and positioning biopharmadive.com biopharmadive.com; AbbVie Rinvoq AA trial via FiercePharma fiercepharma.com; Lancet Neurology SAPPHIRE trial results neurologylive.com neurologylive.com; Reuters – Kite/Gilead’s Interius acquisition reuters.com and Interius press release interiusbio.com; PharmExec on XOMA-Mural deal ts2.tech; Reuters – J&J $2B NC facility and quote ts2.tech ts2.tech; Reuters – Apollo Hospitals stake sale ts2.tech; BiopharmaTrend on Kyorin adopting Elix AI platform biopharmatrend.com biopharmatrend.com; Laotian Times – Amgen Golden Ticket
23 August 2025
·
1 2 3

Stock Market Today

Financial services stocks rally as XLF jumps, Dow hits 50,000 — what to watch next week

Financial services stocks rally as XLF jumps, Dow hits 50,000 — what to watch next week

7 February 2026
U.S. financial stocks rose Friday, with the XLF fund up 1.8% and the Dow closing above 50,000 for the first time, gaining 2.47%. Goldman Sachs jumped 4.3%, JPMorgan 3.9%, and Citigroup 6.0%. The Federal Reserve held rates steady, and San Francisco Fed President Mary Daly signaled possible cuts this year. Investors await January jobs and inflation data next week.
Data Center Stocks Surge Into the Weekend: Digital Realty, Equinix and Vertiv Set Up a Big Week Ahead

Data Center Stocks Surge Into the Weekend: Digital Realty, Equinix and Vertiv Set Up a Big Week Ahead

7 February 2026
Digital Realty, Equinix, and Vertiv shares surged Friday, with Vertiv up 10% and Digital Realty rising 4.1%, as investors rotated back into AI-linked data center stocks. The move followed Amazon’s $200 billion and Alphabet’s $175–185 billion 2026 capex targets. Digital Realty set 2026 core FFO guidance at $7.90 to $8.00 per share. Wall Street ended the week broadly higher, led by chipmakers.
Go toTop